Clinical trial
'Thrombectomy in High-Risk Pulmonary Embolism - Device Versus Thrombolysis Netherlands': TORPEDO-NL
NCT06833827 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 'Thrombectomy in High-Risk Pulmonary Embolism - Device Versus Thrombolysis Netherlands': TORPEDO-NL
- Lead sponsor
- Leiden University Medical Center
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 28, 2025
- Completion date
- January 31, 2029
- Enrollment
- 111 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pulmonary embolism acute